NovoCure Competitors and Similar CompaniesClear all
NovoCure's competitors and similar companies include Lyell and Silverback Therapeutics.
 NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors. |  Silverback Therapeutics Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases. | ||
Founding Date | Founding Date 2000 | Founding Date 2018 | Founding Date 2016 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Seattle, US HQ | |
Employees | Employees 1,488 | Employees 188 | Employees 9067% increase |
Valuation ($) | Valuation ($) 1.8 b | Valuation ($) 243.3 m | Valuation ($) 550.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) $655.4m (FY, 2025) | Revenue (est.) $36k (FY, 2025) | Revenue (est.) $1.3m (FY, 2022) |
Net income | Net income ($136.2m) (FY, 2025) | Net income ($274.4m) (FY, 2025) | Net income ($34.7m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Lyell
HQ
South San Francisco, US
Employees
188
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View companySilverback Therapeutics
HQ
Seattle, US
Employees
90
Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.
View company